Showing 41 - 60 results of 346 for search '"ovarian cancer"', query time: 0.06s Refine Results
  1. 41
  2. 42
  3. 43

    Fertility-Sparing Surgery in Early Epithelial Ovarian Cancer: A Viable Option? by Christina Fotopoulou, Ioana Braicu, Jalid Sehouli

    Published 2012-01-01
    “…Epithelial ovarian cancer (EOC) continues to represent one of the most lethal conditions in women in the western countries. …”
    Get full text
    Article
  4. 44
  5. 45
  6. 46
  7. 47
  8. 48
  9. 49

    Serum folate receptor α (sFR) in ovarian cancer diagnosis and surveillance by Batoul Farran, Samet Albayrak, Judith Abrams, Michael A. Tainsky, Nancy K. Levin, Robert Morris, Larry H. Matherly, Manohar Ratnam, Ira Winer

    Published 2019-03-01
    “…Abstract Novelty and Impact Statement: Our findings suggest that soluble folate receptor (sFR) could be used in both the initial diagnosis and surveillance of patients with ovarian cancer. Our cohort constitutes one of the largest comparison groups for sFR analyzed so far. …”
    Get full text
    Article
  10. 50

    DGAT1 Expression Promotes Ovarian Cancer Progression and Is Associated with Poor Prognosis by Leilei Xia, Ye Wang, Shengyun Cai, Mingjuan Xu

    Published 2021-01-01
    “…Background. Ovarian cancer is the most fatal gynecological malignancy. …”
    Get full text
    Article
  11. 51

    Predictive and Prognostic Value of sPRR in Patients with Primary Epithelial Ovarian Cancer by Katrin Kreienbring, Annika Franz, Rolf Richter, Duska Dragun, Harald Heidecke, Ralf Dechend, Dominik N. Muller, Jalid Sehouli, Elena I. Braicu

    Published 2016-01-01
    “…The purpose of the present study was to analyze the predictive and prognostic role of soluble (pro)renin receptor (sPRR) as a biomarker for clinicopathological outcome in patients with primary epithelial ovarian cancer (EOC). As part of the renin-angiotensin system (RAS) whose activity is known to increase in ovarian cancer patients, the relation of sPRR and ovarian cancer should be further investigated. …”
    Get full text
    Article
  12. 52

    Implication of fibroblast growth factor 7 in ovarian cancer metastases and patient survival by Laura F. Mortan, Laura F. Mortan, Brooke A. Meelheim, Justin Garland, Justin Garland, Jacqueline A. Bohn, Zitha Redempta Isingizwe, Doris M. Benbrook, Doris M. Benbrook

    Published 2025-01-01
    “…Background/ObjectivesPatients with ovarian cancer commonly experience metastases and recurrences, which contribute to high mortality. …”
    Get full text
    Article
  13. 53
  14. 54

    Repurposing Drugs in Controlling Recurrent Platinum-Resistant Clear-Cell Ovarian Cancer by Woraporn Sinsuwan, Phawit Norchai

    Published 2023-01-01
    “…Recurrent platinum-resistant clear-cell ovarian cancer has a low overall survival duration of 7-8 months, making it a fatal disease. …”
    Get full text
    Article
  15. 55

    DOCK4 Is a Platinum-Chemosensitive and Prognostic-Related Biomarker in Ovarian Cancer by Qianqian Zhao, Jie Zhong, Ping Lu, Xiao Feng, Ying Han, Chenqi Ling, Wenke Guo, Weijin Zhou, Fudong Yu

    Published 2021-01-01
    “…In conclusion, DOCK4 is potentially associated with immune cell infiltration and represents a valuable prognostic biomarker in ovarian cancer patients.…”
    Get full text
    Article
  16. 56
  17. 57
  18. 58

    Exosomal miR-543 Inhibits the Proliferation of Ovarian Cancer by Targeting IGF2 by Shupei Zhang, Diling Pan, Shaoyu Zhang, Qiumei Wu, Lan Zhen, Shihuang Liu, Jingjing Chen, Rong Lin, Qiuhua Hong, Xiangqin Zheng, Huan Yi

    Published 2022-01-01
    “…Objective. Ovarian cancer (OvCa) is the most lethal gynaecological malignancy worldwide. …”
    Get full text
    Article
  19. 59
  20. 60